These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2413746)

  • 1. [A study of prostatic tissue levels of cefoperazone].
    Yoshida H; Hoshino M; Haraguchi C; Ogawa Y; Kawai N; Sakurai H; Ishihara Y; Higaki Y; Imamura K
    Hinyokika Kiyo; 1985 May; 31(5):871-4. PubMed ID: 2413746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of cefoperazone prostatic tissue levels: difference between the gland and capsule].
    Fukushima S; Miura T; Kondo I; Fujii H; Hirokawa M; Iwasaki A; Ishizuka E; Kitajima N
    Hinyokika Kiyo; 1983 Jan; 29(1):87-93. PubMed ID: 6203376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime].
    Ikeda S; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Aug; 30(8):1135-42. PubMed ID: 6083722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on the levels of cefoperazone in urological organs].
    Fukatsu H; Waki M; Hatano Y; Hiraiwa S; Kikuchi T; Muramatsu T; Yamada Y; Nishikawa E; Satoh T; Honda N
    Hinyokika Kiyo; 1985 Jun; 31(6):1085-91. PubMed ID: 4061208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffusion of sulbactam and cefoperazone into the prostatic tissue].
    Okamura K; Hashimoto H; Morikawa M; Saga Y; Nishimoto M; Yachiku S; Osani H; Yamauchi K
    Hinyokika Kiyo; 1989 Apr; 35(4):727-34. PubMed ID: 2735275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the prostatic tissue levels of cefmenoxime (CMX)].
    Kataoka K; Kaneko S; Kurita T
    Hinyokika Kiyo; 1985 Feb; 31(2):273-9. PubMed ID: 2409786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of operative procedures on prostatic tissue concentration of antibiotics].
    Kawashima T; Miyakita H; Okada K; Kawamura N; Ookoshi M
    Hinyokika Kiyo; 1985 Sep; 31(9):1657-60. PubMed ID: 4083221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of cefoperazone concentration in human lung tissue].
    Monden Y; Fujimoto Y; Nakahara K
    Jpn J Antibiot; 1986 Jan; 39(1):57-62. PubMed ID: 3702062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ofloxacin concentration in prostatic tissue].
    Kawauchi A; Kamoi K; Ohne T; Imada N; Kitamori T; Terasaki T; Watanabe H
    Hinyokika Kiyo; 1993 Dec; 39(12):1191-3. PubMed ID: 7506868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentration level of latamoxef sodium (LMOX) in prostatic tissue].
    Takao M; Matsuzaki S; Ao T; Nagakura K; Fujioka T; Hata M; Nakamura H; Hayakawa M
    Hinyokika Kiyo; 1985 Mar; 31(3):539-43. PubMed ID: 2411116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the concentration of cefminox sodium in serum and prostatic tissue].
    Sasagawa I
    Hinyokika Kiyo; 1990 Jun; 36(6):737-9. PubMed ID: 1700586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum and prostatic tissue concentration of ceftizoxime (CZX) after intravenous administration in cases of benign prostatic hypertrophy].
    Wakatsuki A; Nishio S; Morita M; Takeuchi M; Murase M
    Hinyokika Kiyo; 1985 Nov; 31(11):2080-4. PubMed ID: 2418663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on transfer of ceftizoxime into prostatic and vesical tissues].
    Katsumi T; Murayama K
    Hinyokika Kiyo; 1984 Feb; 30(2):259-64. PubMed ID: 6204521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Panou C; Adamakis I; Giamarellou H
    J Urol; 2001 Jan; 165(1):97-9. PubMed ID: 11125373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoperazone pharmacokinetics and sputum levels after single/multiple i.m. injections in bronchopneumopathic patients and bone, pulmonary and prostatic tissue penetration.
    Braga PC; Scaglione F; Villa S; Scarpazza G; Gagliardi V; Biella G; Manganelli V; Paiola G; Fraschini F
    Int J Clin Pharmacol Res; 1983; 3(5):349-55. PubMed ID: 6678828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study on adenomatous prostate tissue concentrations of cefoperazone. Clinical efficacy and patient tolerance of intramuscular cefoperazone treatment of chronic bacterial prostatitis.
    Melloni D; Ammatuna P; Formica P; Falletta V; Gaglio F; Cacciatore M; Messina G
    Chemotherapy; 1989; 35(6):410-5. PubMed ID: 2612230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies with cefoperazone in the biliary disease].
    Morinaga T; Furukawa M; Nakata T; Yamada R; Itoh S; Maeda S; Itose K; Ohtsubo M
    Jpn J Antibiot; 1985 Jan; 38(1):128-32. PubMed ID: 3989972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies on Suncefal (cefpiramide) concentration in prostatic tissue and bladder wall].
    Okishio N; Yonezu M; Hanai S; Ishiguro K; Yanaoka M; Naide Y
    Hinyokika Kiyo; 1988 Mar; 34(3):551-4. PubMed ID: 2455441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.